Amalgamated Bank Athenex, Inc. Transaction History

Amalgamated Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $5,234 - $11,617	-12,767 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.79 - $1.59 $669 - $1,346	-847 Reduced 6.22%	12,767 $11,000
Q4 2021 Feb 15, 2022	SELL	$1.36 - $2.94 $643 - $1,390	-473 Reduced 3.36%	13,614 $19,000
Q3 2021 Oct 29, 2021	SELL	$2.97 - $4.84 $1,568 - $2,555	-528 Reduced 3.61%	14,087 $42,000
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $16,405 - $22,684	4,422 Added 43.38%	14,615 $68,000
Q1 2021 May 13, 2021	SELL	$4.08 - $14.75 $3,337 - $12,065	-818 Reduced 7.43%	10,193 $44,000
Q4 2020 Feb 12, 2021	BUY	$11.06 - $14.01 $121,781 - $154,264	11,011 New	11,011 $121,000
Q3 2020 Oct 30, 2020	SELL	$10.26 - $14.55 $120,811 - $171,326	-11,775 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$7.11 - $13.76 $1,400 - $2,710	-197 Reduced 1.65%	11,775 $162,000
Q1 2020 May 13, 2020	SELL	$5.71 - $15.85 $365 - $1,014	-64 Reduced 0.53%	11,972 $93,000
Q4 2019 Feb 13, 2020	BUY	$9.6 - $17.75 $14,390 - $26,607	1,499 Added 14.23%	12,036 $184,000
Q3 2019 Nov 13, 2019	SELL	$12.16 - $21.0 $1,070 - $1,848	-88 Reduced 0.83%	10,537 $128,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $100,300 - $210,375	10,625 New	10,625 $210,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.